-
Raymond R.
Sarlot and Karl
Kantarjian of Sarlot-
Kantarjian, a real
estate development firm, for $1.1 million. Sarlot-
Kantarjian planned to
expand the hotel...
-
Myeloid Leukemia". 2012-09-28.
Retrieved 28
September 2012.
Batty GN,
Kantarjian H, Issa JP,
Jabbour E,
Santos FP,
McCue D, et al. (June 2010). "Feasibility...
- 1172/JCI31771. PMC 1934591. PMID 17671636.
Faderl S,
Talpaz M,
Estrov Z,
Kantarjian HM (August 1999). "Chronic
myelogenous leukemia:
biology and therapy"...
- PMID 23523389.
Baljevic M,
Jabbour E, O'Brien S,
Kantarjian HM (2016). "Acute
Lymphoblastic Leukemia". In
Kantarjian HM,
Wolff RA (eds.). The MD
Anderson Manual...
- Oncology. 24 (24): 3895–903. doi:10.1200/JCO.2005.05.4346. PMID 16921040.
Kantarjian HM, O'Brien S, Shan J,
Aribi A, Garcia-Manero G,
Jabbour E, et al. (January...
-
protein synthesis from
mRNAs that have
already commenced translation.
Kantarjian HM, O'Brien S,
Cortes J (October 2013). "Homoharringtonine/omacetaxine...
- doi:10.1002/cncr.22457. PMID 17219444. De
Padua Silva L, de Lima M,
Kantarjian H, et al. (January 2009). "Feasibility of allo-SCT
after hypomethylating...
-
Retrieved 2
April 2018. {{cite book}}: |website=
ignored (help)
Cortes JE,
Kantarjian HM, Brümmendorf TH, Kim DW,
Turkina AG, Shen ZX, et al. (October 2011)...
- info.pmda.go.jp (in ****anese).
Retrieved 2021-12-28.
Jabbour E, Paul S,
Kantarjian H (July 2021). "The
clinical development of antibody-drug
conjugates -...
- (8th ed.). Philadelphia: Saunders. ISBN 978-1-4160-2973-1.
Kurzrock R,
Kantarjian HM,
Druker BJ,
Talpaz M (May 2003). "Philadelphia chromosome-positive...
